Pyrotinib Maleate, CDK4/6 Inhibitor and Letrozole in Combination for Stage II-III TPBC: a Phase II Trial
Clinical trial NCT04486911 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04486911
- Sponsor
- Shengjing Hospital
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-27
- Primary completion
- 2026-12-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.